デフォルト表紙
市場調査レポート
商品コード
1470859

強度変調放射線治療市場:適応症、放射線タイプ、エンドユーザー別-2024-2030年の世界予測

Intensity Modulated Radiotherapy Market by Indication (Breast Cancer, Gastrointestinal Cancer, Gynecological Cancer), Radiation Type (Carbon-Ion Radiation, Electron Radiation, Photon Radiation), End-User - Global Forecast 2024-2030

出版日: | 発行: 360iResearch | ページ情報: 英文 192 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.74円
強度変調放射線治療市場:適応症、放射線タイプ、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年04月17日
発行: 360iResearch
ページ情報: 英文 192 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

強度変調放射線治療市場規模は2023年に23億米ドルと推計され、2024年には24億3,000万米ドルに達し、CAGR 5.36%で2030年には33億2,000万米ドルに達すると予測されています。

強度変調放射線治療(IMRT)は、より広範な腫瘍学および放射線治療分野の中で重要なセグメントを構成しており、正確にターゲットを絞ったがん治療ソリューションの提供に注力しています。IMRTは、コンピュータ制御のリニアアクセラレータを利用して腫瘍の形状に合わせた正確な線量を照射し、周囲の健康な組織の被曝を最小限に抑える先進的な放射線治療です。この技術は、従来の放射線治療技術に比べて有害な副作用を減らし、患者の転帰を改善する能力があるため、近年大きな支持を得ています。IMRTの世界市場の成長を後押ししている要因は他にもいくつかあり、その中には世界のがん疾患の有病率の上昇も含まれます。第2に、CTスキャン、MRIスキャン、PETスキャンなどの医療画像技術の進歩により、計画段階や治療段階において腫瘍の優れた可視化が可能になり、IMRTの有効性がさらに高まっています。このような前向きな動向が市場の成長を後押ししているにもかかわらず、高度なIMRT装置の取得と維持に関連する資本コストが高いため、限られた予算や資源の乏しい環境で運営されているヘルスケア施設では、IMRTへのアクセスが制限されています。さらに、IMRTの計画と照射は複雑であるため、臨床医には専門的な訓練と専門知識が必要であり、地域によっては労働力に制約が生じる可能性があり、医療施設全体への普及が制限されます。さらに、既存技術の改良や新規の標的放射線治療技術の開発に関する研究は、市場成長の機会を数多く提供しています。技術革新、臨床応用の継続的な進歩、研究者、臨床医、政府機関などの利害関係者間の緊密な協力により、IMRTががん患者に提供する利益を最適化することで、世界の強度変調放射線治療市場に有利な機会が生まれることが期待されます。

主な市場の統計
基準年[2023] 23億米ドル
予測年[2024] 24億3,000万米ドル
予測年 [2030] 33億2,000万米ドル
CAGR(%) 5.36%

適応症さまざまな適応症において、副作用の軽減と患者生活の質の向上を目的としたIMRTの応用が拡大

乳がん症例では、IMRTは、腫瘍が大きかったり不規則な形をしていたりする患者、乳房の部分照射が必要な患者、心臓関連の合併症のリスクがある左側乳がんの患者にとって特に有益です。IMRTは、食道、胃、膵、直腸、肛門などの消化器(GI)がんの管理において重要な役割を果たしています。腫瘍が肝臓、腎臓、脊髄などの重要な臓器の近くに存在することが多いこれらの複雑な症例では、IMRTにより、近くの構造物への被曝を抑えながら、より高線量の放射線を照射することができます。子宮頸がんや子宮内膜がんなどの婦人科がんでは、外科的介入では病状の進行を抑制できないことが多いです。したがって、局所制御を高め再発を減少させるために、IMRTを用いた外部照射療法(EBRT)などの術後補助療法が推奨されます。IMRTでは、膀胱、直腸、腸などのリスクのある臓器を温存できるため、従来の放射線治療法に比べて長期的な合併症が減少し、性機能が改善します。IMRTは肺がん患者、特に非小細胞肺がん(NSCLC)患者に対する治療の重要な武器となっています。この技術により、脊髄や心臓のような周囲の健康な組織への損傷を抑えながら、腫瘍に高線量の放射線を照射することができます。前立腺がんと診断された男性にとって、IMRTは副作用を最小限に抑えた非常に効果的な治療法です。前立腺を正確にターゲットにすることで、直腸や膀胱に関連する合併症を増加させることなく、放射線量を増加させることができます。

放射線の種類:さまざまな腫瘍の大きさ、部位、病期を治療できる汎用性の高い光子療法への高い嗜好性

炭素イオン放射線療法は、炭素イオンを利用して、周囲の健康な組織へのダメージを最小限に抑えながら、腫瘍に高精度の放射線を照射します。このタイプの放射線は、他のタイプの放射線に比べて組織の深部まで浸透する能力があるため、従来の放射線治療に抵抗性のある深在性腫瘍の治療に特に効果的です。炭素イオン療法は、複雑な腫瘍や放射線抵抗性の腫瘍があり、従来の放射線療法が有効でない患者に適しています。電子線治療では、電子ビームを使用して表在性の腫瘍に放射線を照射します。このタイプの治療は、皮膚がんやリンパ腫などの表在性がんの治療に適しています。光子療法はIMRTで使用される最も一般的な放射線で、高エネルギーX線を用いてがん細胞を破壊します。組織の深部まで透過する能力があるため、幅広い種類の腫瘍や部位を効果的に治療することができます。陽子線治療は、周囲の健康な組織への影響を最小限に抑えながら、腫瘍に高精度の放射線を照射するために陽子を利用します。より高い精度で腫瘍を狙い撃ちできる陽子線治療は、小児患者や重要臓器の近くにある腫瘍の治療に特に有用です。

エンドユーザー:最新技術に投資する資金力のある病院での採用が増加

病院は、高度な放射線治療を必要とする多くのがん患者を治療しているため、強度変調放射線治療(IMRT)の重要なエンドユーザーです。病院に対するニーズに基づく選好には、最先端技術を提供し、優れた患者ケアを提供し、臨床転帰を改善する能力が含まれます。しかし、独立系の放射線治療センターは、従来の病院の枠にとらわれずに放射線治療を提供することに特化しています。IMRTのような特定の治療法に特化したニッチプレーヤーとして、これらのセンターは通常、他の周辺組織へのダメージを最小限に抑えながら、高度に的を絞った線量を照射できる最先端技術を必要とします。独立放射線治療センターが機器を選ぶ際には、費用対効果と拡張性が大きく影響します。

地域別インサイト

南北アメリカ地域では、米国がIMRTの世界市場で大きなシェアを占めているが、これは高度なヘルスケアインフラ、確立された償還政策、最先端医療技術の採用増加によるものです。この分野の研究開発活動には、民間部門と公的部門の両方からの投資が大きく貢献しています。ブラジル、メキシコ、アルゼンチンなどの中南米諸国でも、国民のがん罹患率が上昇していることから、IMRTサービスの需要が増加しています。ヘルスケアのインフラが徐々に整備され、がん治療施設を強化する政府の取り組みが活発化していることが、この分野のさらなる成長に拍車をかけています。欧州では、急速な技術進歩と強固なヘルスケアシステムにより、多くの国でIMRT技術が広く採用されています。その結果、ドイツ、フランス、イタリア、スペイン、英国などの欧州主要国では、高精度放射線治療を求めるがん患者の間でIMRTの採用率が大幅に上昇しています。さらに、がん医療サービスを改善するための政府や非営利団体による継続的な取り組みが、中東・アフリカ地域の医療提供者の間でIMRT導入への道を徐々に開いています。アジア太平洋地域は強度変調放射線治療市場において大きな成長の可能性を秘めており、その主な原動力は人口の多さとがん罹患率の増加です。過去10年間で、中国、インド、日本、韓国、オーストラリアを含む各国の医療インフラが大きく改善されました。このため、これらの国の患者にとって、IMRTのような先進的ながん治療オプションへのアクセスが向上しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、強度変調放射線治療市場の評価において極めて重要です。事業戦略と製品満足度に関連する主要指標を調査し、ベンダーの包括的な評価を提供します。この綿密な分析により、ユーザーは各自の要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功の度合いが異なる4つの象限に分類されます:フォアフロント(F)、パスファインダー(P)、ニッチ(N)、バイタル(V)です。

市場シェア分析

市場シェア分析は、強度変調放射線治療市場におけるベンダーの現状について、洞察に満ちた詳細な調査を提供する包括的なツールです。全体的な収益、顧客基盤、その他の主要指標についてベンダーの貢献度を綿密に比較・分析することで、企業の業績や市場シェア争いの際に直面する課題について理解を深めることができます。さらに、この分析により、調査対象基準年に観察された累積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合特性に関する貴重な考察が得られます。このような詳細レベルの拡大により、ベンダーはより多くの情報に基づいた意思決定を行い、市場で競争優位に立つための効果的な戦略を考案することができます。

本レポートは、以下の側面に関する貴重な洞察を提供しています:

1.市場の浸透度:主要企業が提供する市場に関する包括的な情報を提示しています。

2.市場の開拓度:有利な新興市場を深く掘り下げ、成熟市場セグメントにおける浸透度を分析しています。

3.市場の多様化:新製品の発売、未開拓の地域、最近の開発、投資に関する詳細な情報を提供します。

4.競合の評価と情報:市場シェア、戦略、製品、認証、規制状況、特許状況、主要企業の製造能力について徹底的な評価を行います。

5.製品開発およびイノベーション:将来の技術、研究開発活動、画期的な製品開発に関する知的洞察を提供します。

本レポートは、以下のような主要な質問に対応しています:

1.強度変調放射線治療市場の市場規模および予測は?

2.強度変調放射線治療市場の予測期間中に投資を検討すべき製品、セグメント、用途、分野は何か?

3.強度変調放射線治療市場の技術動向と規制枠組みは?

4.強度変調放射線治療市場における主要ベンダーの市場シェアは?

5.強度変調放射線治療市場への参入に適した形態や戦略的手段は?

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中でがんの発生率が増加
      • がん管理に対する政府の取り組みの増加
      • 世界のヘルスケア費の増加
    • 抑制要因
      • がん治療の高額な費用
    • 機会
      • 強度変調放射線治療における継続的なイノベーション
      • 腫瘍学分野における革新的な治療法の導入拡大
    • 課題
      • 熟練した専門家の不足
  • 市場セグメンテーション分析
    • 適応症:さまざまな適応症において副作用の軽減と患者の生活の質の向上を目的としたIMRTの適用が拡大
    • 放射線の種類:さまざまな腫瘍のサイズ、場所、段階を治療するための多目的光子治療が優先されます。
    • エンドユーザー:最新のイノベーションに投資する資金力のある病院による導入が増加
  • 市場ディスラプション分析
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 価格分析
  • 技術分析
  • 特許分析
  • 貿易分析
  • 規制枠組みの分析

第6章 強度変調放射線治療市場適応症別

  • 乳がん
  • 消化器がん
  • 婦人科がん
  • 肺がん
  • 前立腺がん

第7章 強度変調放射線治療市場放射線の種類別

  • 炭素イオン放射線
  • 電子放射線
  • 光子放射
  • 陽子放射線

第8章 強度変調放射線治療市場:エンドユーザー別

  • 病院
  • 独立放射線治療センター

第9章 南北アメリカの強度変調放射線治療市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の強度変調放射線治療市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの強度変調放射線治療市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス、2023
  • 競合シナリオ分析
    • M42とQSTが炭素イオン治療に関する調査を共有する協定を締結
    • IBAは、世界中の腫瘍医に陽子線治療のトレーニングを提供するために、アポロ陽子線がんセンターと独占的に提携しています。
    • 英国初の乳がん陽子線治療試験開始
  • 戦略分析と提言

第13章 競合ポートフォリオ

  • 主要企業プロファイル
  • 主要製品ポートフォリオ
図表

LIST OF FIGURES

  • FIGURE 1. INTENSITY MODULATED RADIOTHERAPY MARKET RESEARCH PROCESS
  • FIGURE 2. INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. INTENSITY MODULATED RADIOTHERAPY MARKET DYNAMICS
  • FIGURE 7. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. INTENSITY MODULATED RADIOTHERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. INTENSITY MODULATED RADIOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. INTENSITY MODULATED RADIOTHERAPY MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY BREAST CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY GASTROINTESTINAL CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY GASTROINTESTINAL CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY GYNECOLOGICAL CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY LUNG CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY PROSTATE CANCER, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY CARBON-ION RADIATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY CARBON-ION RADIATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY ELECTRON RADIATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY ELECTRON RADIATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY PHOTON RADIATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY PHOTON RADIATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY PROTON RADIATION, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY PROTON RADIATION, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY HOSPITALS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDEPENDENT RADIOTHERAPY CENTERS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 36. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 43. ARGENTINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 44. ARGENTINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 49. BRAZIL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 50. BRAZIL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 51. BRAZIL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 52. BRAZIL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 55. CANADA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 56. CANADA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 57. CANADA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 58. CANADA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 59. CANADA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 60. CANADA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 61. MEXICO INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 62. MEXICO INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 63. MEXICO INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 64. MEXICO INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 65. MEXICO INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 66. MEXICO INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 67. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 68. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 69. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 70. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 71. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 72. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 73. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 74. UNITED STATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 75. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 76. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 83. AUSTRALIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 84. AUSTRALIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 86. AUSTRALIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 88. AUSTRALIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 89. CHINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 90. CHINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 91. CHINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 92. CHINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 93. CHINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 94. CHINA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 95. INDIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 96. INDIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 97. INDIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 98. INDIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 99. INDIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 100. INDIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 101. INDONESIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 102. INDONESIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 103. INDONESIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 104. INDONESIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 105. INDONESIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 106. INDONESIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 107. JAPAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 108. JAPAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 109. JAPAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 110. JAPAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 111. JAPAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 112. JAPAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 113. MALAYSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 114. MALAYSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 115. MALAYSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 116. MALAYSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 117. MALAYSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 118. MALAYSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 119. PHILIPPINES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 120. PHILIPPINES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 122. PHILIPPINES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 124. PHILIPPINES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 125. SINGAPORE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 126. SINGAPORE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 127. SINGAPORE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 128. SINGAPORE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 129. SINGAPORE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 130. SINGAPORE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 131. SOUTH KOREA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 132. SOUTH KOREA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 134. SOUTH KOREA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 136. SOUTH KOREA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 137. TAIWAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 138. TAIWAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 139. TAIWAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 140. TAIWAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 141. TAIWAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 142. TAIWAN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 143. THAILAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 144. THAILAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 145. THAILAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 146. THAILAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 147. THAILAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 148. THAILAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 149. VIETNAM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 150. VIETNAM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 151. VIETNAM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 152. VIETNAM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 153. VIETNAM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 154. VIETNAM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 155. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 156. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 163. DENMARK INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 164. DENMARK INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 165. DENMARK INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 166. DENMARK INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 167. DENMARK INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 168. DENMARK INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 169. EGYPT INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 170. EGYPT INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 171. EGYPT INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 172. EGYPT INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 173. EGYPT INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 174. EGYPT INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 175. FINLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 176. FINLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 177. FINLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 178. FINLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 179. FINLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 180. FINLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 181. FRANCE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 182. FRANCE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 183. FRANCE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 184. FRANCE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 185. FRANCE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 186. FRANCE INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 187. GERMANY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 188. GERMANY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 189. GERMANY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 190. GERMANY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 191. GERMANY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 192. GERMANY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 193. ISRAEL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 194. ISRAEL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 195. ISRAEL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 196. ISRAEL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 197. ISRAEL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 198. ISRAEL INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 199. ITALY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 200. ITALY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 201. ITALY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 202. ITALY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 203. ITALY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 204. ITALY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 205. NETHERLANDS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 206. NETHERLANDS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 208. NETHERLANDS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 210. NETHERLANDS INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 211. NIGERIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 212. NIGERIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 213. NIGERIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 214. NIGERIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 215. NIGERIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 216. NIGERIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 217. NORWAY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 218. NORWAY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 219. NORWAY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 220. NORWAY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 221. NORWAY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 222. NORWAY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 223. POLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 224. POLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 225. POLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 226. POLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 227. POLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 228. POLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 229. QATAR INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 230. QATAR INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 231. QATAR INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 232. QATAR INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 233. QATAR INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 234. QATAR INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 235. RUSSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 236. RUSSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 237. RUSSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 238. RUSSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 239. RUSSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 240. RUSSIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 241. SAUDI ARABIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 242. SAUDI ARABIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 244. SAUDI ARABIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 246. SAUDI ARABIA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 247. SOUTH AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 248. SOUTH AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH AFRICA INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 253. SPAIN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 254. SPAIN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 255. SPAIN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 256. SPAIN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 257. SPAIN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 258. SPAIN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 259. SWEDEN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 260. SWEDEN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 261. SWEDEN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 262. SWEDEN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 263. SWEDEN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 264. SWEDEN INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 265. SWITZERLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 266. SWITZERLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 268. SWITZERLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 270. SWITZERLAND INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 271. TURKEY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 272. TURKEY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 273. TURKEY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 274. TURKEY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 275. TURKEY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 276. TURKEY INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 277. UNITED ARAB EMIRATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 278. UNITED ARAB EMIRATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED KINGDOM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED KINGDOM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY INDICATION, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED KINGDOM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY RADIATION TYPE, 2024-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 288. UNITED KINGDOM INTENSITY MODULATED RADIOTHERAPY MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 289. INTENSITY MODULATED RADIOTHERAPY MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 290. INTENSITY MODULATED RADIOTHERAPY MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-CF6C60CF95AB

[192 Pages Report] The Intensity Modulated Radiotherapy Market size was estimated at USD 2.30 billion in 2023 and expected to reach USD 2.43 billion in 2024, at a CAGR 5.36% to reach USD 3.32 billion by 2030.

The Intensity Modulated Radiotherapy (IMRT) constitutes a significant segment within the broader oncology and radiotherapy sectors, focusing on providing precisely targeted cancer treatment solutions. IMRT is an advanced form of radiotherapy that utilizes computer-controlled linear accelerators to deliver precise doses that conform to the shape of a tumor, minimizing the exposure of surrounding healthy tissues. This technology has gained substantial traction in recent years owing to its ability to reduce harmful side effects and improve patient outcomes in comparison to traditional radiotherapy techniques. Several other factors are responsible for driving growth in the global IMRT market, which includes the rising global prevalence of cancer diseases. Secondly, advancements in medical imaging technologies such as CT scans, MRI scans, and PET scans have further enhanced the efficacy of IMRT by providing superior tumor visualization during the planning and treatment stages. Despite these positive trends fueling market growth, high capital costs associated with acquiring and maintaining sophisticated IMRT equipment limit the accessibility for healthcare facilities operating on constrained budgets or resource-poor settings. Additionally, the complexity of IMRT planning and delivery requires specialized training and expertise for clinicians, thus potentially creating workforce limitations in some regions and limiting its widespread adoption across healthcare facilities. Moreover, research on improving existing technologies or developing novel targeted radiation therapy techniques presents numerous opportunities for market growth. Ongoing advancements in technological innovation, clinical applications, and intense collaboration between stakeholders, such as researchers, clinicians, and government agencies, to optimize the benefits offered by IMRT for cancer patients are expected to create lucrative opportunities for the global intensity modulated radiotherapy market.

KEY MARKET STATISTICS
Base Year [2023] USD 2.30 billion
Estimated Year [2024] USD 2.43 billion
Forecast Year [2030] USD 3.32 billion
CAGR (%) 5.36%

Indication: Growing applications of IMRT for reduced side effects and enhanced quality of patient life across various indications

In breast cancer cases, IMRT is particularly beneficial for patients with large or irregularly shaped tumors, those requiring partial breast irradiation, and individuals with left-sided breast cancer who are at risk for heart-related complications. IMRT plays a significant role in the management of gastrointestinal (GI) cancers, including esophageal, gastric, pancreatic, rectal, and anal malignancies. For these complex cases where tumors are often located near critical organs such as the liver, kidneys, or spinal cord, IMRT allows higher doses of radiation delivery while reducing exposure to nearby structures. In gynecological cancers such as cervical and endometrial cancer, surgical interventions are often insufficient in controlling disease progression. Thus, postoperative adjuvant treatments such as external beam radiation therapy (EBRT) using IMRT are recommended to increase local control and decrease recurrence. IMRT allows for better sparing of organs at risk, such as the bladder, rectum, and bowel, resulting in reduced long-term complications and improved sexual function compared to conventional radiotherapy techniques. IMRT has become an important addition to the treatment arsenal for lung cancer patients, particularly those with non-small cell lung cancer (NSCLC). This technique enables the delivery of high doses of radiation to tumors while limiting damage to surrounding healthy tissues like the spinal cord and heart. For men diagnosed with prostate cancer, IMRT offers a highly effective treatment option that minimizes side effects. By precisely targeting the prostate gland, this technique allows for escalated radiation doses without increasing complications related to the rectum or bladder.

Radiation Type: Higher preferences for versatile photon therapy to treat various tumor sizes, locations, and stages

Carbon-ion radiation therapy utilizes carbon ions to deliver a highly precise dose of radiation to tumors with minimal damage to surrounding healthy tissues. This type of radiation is particularly effective for treating deep-seated tumors that are resistant to conventional radiotherapy owing to their ability to penetrate deeper into tissue compared to other types of radiation. Carbon-ion therapy can be preferred for patients with complex or radioresistant tumors where conventional radiotherapy may not be as effective. Electron Radiation therapy employs a beam of electrons to deliver radiation doses to superficial tumors, providing high-dose conformality with rapid dose falloff. This type of therapy is suitable for treating superficial cancers such as skin cancer and lymphoma. Photon therapy is the most common type of radiation used in IMRT and involves high-energy X-rays to destroy cancer cells. It can effectively treat a wide range of tumor types and locations owing to its ability to penetrate deep into tissues. Proton Radiation therapy utilizes protons to deliver a highly precise radiation dose to tumors with minimal impact on surrounding healthy tissues. With the ability to target tumors with greater accuracy, proton therapy is especially useful for treating pediatric patients and tumors located near critical organs.

End-User: Rising adoption by hospitals with greater financial resources to invest in the latest innovations

Hospitals represent a significant end-user segment for intensity modulated radiotherapy (IMRT) as they treat a large number of cancer patients requiring advanced radiation therapy. The need-based preference for hospitals includes the ability to offer cutting-edge technology, deliver superior patient care, and improve clinical outcomes. However, independent radiotherapy centers specialize exclusively in providing radiation therapy treatments outside traditional hospital settings. As a niche player focusing on specific treatment modalities such as IMRT, these centers typically require cutting-edge technology capable of delivering highly targeted doses of radiation while minimizing damage to other surrounding tissues. Independent radiotherapy centers' preference for equipment is heavily influenced by cost-effectiveness and scalability.

Regional Insights

In the Americas region, the United States accounts for a substantial share of the global IMRT market owing to its advanced healthcare infrastructure, well-established reimbursement policies, and increased adoption of cutting-edge medical technologies. Investments from both private and public sectors have contributed significantly to research and development activities in this field. Latin American countries such as Brazil, Mexico, and Argentina also witness an uptick in demand for IMRT services attributed to increasing cancer prevalence rates amongst their populations. The gradual improvement of healthcare infrastructure combined with increasing government initiatives to boost cancer care facilities is fueling further growth in this segment. In Europe, rapid technological advancements and robust healthcare systems have allowed many countries to adopt IMRT techniques widely. As a result, major European nations, including Germany, France, Italy, Spain, and the UK, have witnessed significant adoption rates for IMRT among cancer patients seeking precision radiotherapy treatments. Moreover, ongoing efforts by governments and non-profit organizations to improve cancer care services are gradually paving the way for the adoption of IMRT among healthcare providers in the Middle East and Africa region. The Asia-Pacific region presents significant potential for growth in the Intensity Modulated Radiotherapy market, primarily driven by its large population size and increasing incidence of cancer cases. The past decade has seen major strides in improving healthcare infrastructure across countries, including China, India, Japan, South Korea, and Australia. This has led to increased accessibility to advanced cancer treatment options like IMRT for patients within these nations.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Intensity Modulated Radiotherapy Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Intensity Modulated Radiotherapy Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Intensity Modulated Radiotherapy Market, highlighting leading vendors and their innovative profiles. These include Accuray Incorporated, Aetna Inc., Brainlab AG, Elekta AB, GE Healthcare, Hitachi, Ltd., Mevion Medical Systems, PMB by ALCEN group, Siemens Healthineers AG, Varian Medical Systems, Inc., and Xstrahl Group.

Market Segmentation & Coverage

This research report categorizes the Intensity Modulated Radiotherapy Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Indication
    • Breast Cancer
    • Gastrointestinal Cancer
    • Gynecological Cancer
    • Lung Cancer
    • Prostate Cancer
  • Radiation Type
    • Carbon-Ion Radiation
    • Electron Radiation
    • Photon Radiation
    • Proton Radiation
  • End-User
    • Hospitals
    • Independent Radiotherapy Centers
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Intensity Modulated Radiotherapy Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Intensity Modulated Radiotherapy Market?

3. What are the technology trends and regulatory frameworks in the Intensity Modulated Radiotherapy Market?

4. What is the market share of the leading vendors in the Intensity Modulated Radiotherapy Market?

5. Which modes and strategic moves are suitable for entering the Intensity Modulated Radiotherapy Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing incidences of cancer across the world
      • 5.1.1.2. Rise in government initiatives for cancer management
      • 5.1.1.3. Increase in healthcare expenditure globally
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of cancer treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Ongoing innovation in Intensity Modulated Radiotherapy
      • 5.1.3.2. Growing adoption of innovative treatment in the oncology field
    • 5.1.4. Challenges
      • 5.1.4.1. Shortage of skilled professionals
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Indication: Growing applications of IMRT for reduced side effects and enhanced quality of patient life across various indications
    • 5.2.2. Radiation Type: Higher preferences for versatile photon therapy to treat various tumor sizes, locations, and stages
    • 5.2.3. End-User: Rising adoption by hospitals with greater financial resources to invest in the latest innovations
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Intensity Modulated Radiotherapy Market, by Indication

  • 6.1. Introduction
  • 6.2. Breast Cancer
  • 6.3. Gastrointestinal Cancer
  • 6.4. Gynecological Cancer
  • 6.5. Lung Cancer
  • 6.6. Prostate Cancer

7. Intensity Modulated Radiotherapy Market, by Radiation Type

  • 7.1. Introduction
  • 7.2. Carbon-Ion Radiation
  • 7.3. Electron Radiation
  • 7.4. Photon Radiation
  • 7.5. Proton Radiation

8. Intensity Modulated Radiotherapy Market, by End-User

  • 8.1. Introduction
  • 8.2. Hospitals
  • 8.3. Independent Radiotherapy Centers

9. Americas Intensity Modulated Radiotherapy Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Intensity Modulated Radiotherapy Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Intensity Modulated Radiotherapy Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. M42 and QST Sign Agreement to Share Research on Carbon Ion Therapy
    • 12.3.2. IBA Partners Exclusively with Apollo Proton Cancer Centre for Providing Proton Beam Therapy Training to Oncologists from Across the Globe
    • 12.3.3. First UK Proton Beam Therapy Trial for Breast Cancer Launches
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio